Effect of Newcastle disease virus on human or rabbit platelets. Aggregation and loss of constituents.
D000227:Adenine Nucleotides / Q000097:blood; D000244:Adenosine Diphosphate / Q000378:metabolism; D000249:Adenosine Monophosphate / Q000494:pharmacology; D000818:Animals; D001792:Blood Platelets / Q000201:enzymology / Q000378:metabolism; D002845:Chromatography; D003402:Creatine Kinase / Q000494:pharmacology; D003594:Cytoplasmic Granules; D004492:Edetic Acid / Q000494:pharmacology; D006387:Hemagglutination, Viral; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008722:Methods; D009522:Newcastle disease virus; D010653:Phenylbutazone / Q000097:blood; D010725:Phosphocreatine / Q000494:pharmacology; D010759:Phosphorus Isotopes; D010973:Platelet Adhesiveness; D011453:Prostaglandins / Q000494:pharmacology; D011817:Rabbits; D012701:Serotonin; D013442:Sulfinpyrazone / Q000494:pharmacology; D013552:Swine; D013921:Thrombocytopenia / Q000209:etiology; D013997:Time Factors
D000227:Adenine Nucleotides; D010759:Phosphorus Isotopes; D011453:Prostaglandins; D010725:Phosphocreatine; D012701:Serotonin; D000249:Adenosine Monophosphate; D000244:Adenosine Diphosphate; D004492:Edetic Acid; D007770:L-Lactate Dehydrogenase; D003402:Creatine Kinase; D010653:Phenylbutazone; D013442:Sulfinpyrazone